CME Cme Group Inc

Price (delayed)

$217.06

Market cap

$77.95B

P/E Ratio

40.57

Dividend/share

$3.55

EPS

$5.35

Enterprise value

$221.62B

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights
The debt has surged by 75% year-on-year and by 14% since the previous quarter
CME's P/E is 49% above its 5-year quarterly average of 27.2 and 19% above its last 4 quarters average of 34.2

Key stats

What are the main financial stats of CME
Market
Shares outstanding
359.14M
Market cap
$77.95B
Enterprise value
$221.62B
Valuations
Price to earnings (P/E)
40.57
Price to book (P/B)
2.91
Price to sales (P/S)
16.86
EV/EBIT
81.62
EV/EBITDA
70.39
EV/Sales
48.06
Earnings
Revenue
$4.61B
EBIT
$2.72B
EBITDA
$3.15B
Free cash flow
$1.89B
Per share
EPS
$5.35
Free cash flow per share
$5.27
Book value per share
$74.53
Revenue per share
$12.87
TBVPS
$411.21
Balance sheet
Total assets
$178.7B
Total liabilities
$151.91B
Debt
$144.74B
Equity
$26.76B
Working capital
$2.84B
Liquidity
Debt to equity
5.41
Current ratio
1.02
Quick ratio
1.01
Net debt/EBITDA
45.63
Margins
EBITDA margin
68.3%
Gross margin
100%
Net margin
41.6%
Operating margin
52.9%
Efficiency
Return on assets
1.3%
Return on equity
7.2%
Return on invested capital
2.3%
Return on capital employed
7.4%
Return on sales
58.9%
Dividend
Dividend yield
1.64%
DPS
$3.55
Payout ratio
66.4%

CME stock price

How has the Cme Group stock price performed over time
Intraday
-1.01%
1 week
1.35%
1 month
9.39%
1 year
36.11%
YTD
19.23%
QTD
12.25%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$4.61B
Gross profit
$4.61B
Operating income
$2.44B
Net income
$1.92B
Gross margin
100%
Net margin
41.6%
The company's net income fell by 19% YoY
The operating income is down by 15% YoY
The gross profit has decreased by 10% YoY
CME's revenue is down by 10% year-on-year

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
P/E
40.57
P/B
2.91
P/S
16.86
EV/EBIT
81.62
EV/EBITDA
70.39
EV/Sales
48.06
CME's P/E is 49% above its 5-year quarterly average of 27.2 and 19% above its last 4 quarters average of 34.2
The EPS has declined by 20% year-on-year
CME's price to book (P/B) is 21% higher than its 5-year quarterly average of 2.4 and 12% higher than its last 4 quarters average of 2.6
The P/S is 25% higher than the 5-year quarterly average of 13.5 and 16% higher than the last 4 quarters average of 14.5
CME's revenue is down by 10% year-on-year

Efficiency

How efficient is Cme Group business performance
The ROIC has contracted by 49% YoY and by 12% from the previous quarter
Cme Group's return on assets has decreased by 43% YoY and by 7% QoQ
Cme Group's return on equity has decreased by 19% YoY
The return on sales has declined by 4.7% year-on-year but it is up by 2.6% since the previous quarter

Dividends

What is CME's dividend history
DPS
$3.55
Dividend yield
1.64%
Payout ratio
66.4%
Recent dividends

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 18% more than its total liabilities
Cme Group's total liabilities has surged by 68% YoY and by 13% QoQ
Cme Group's total assets has soared by 52% YoY and by 11% from the previous quarter
The debt to equity has soared by 75% YoY and by 13% from the previous quarter
The debt has surged by 75% year-on-year and by 14% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.